Opportunity Information: Apply for PAR 19 334
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance opportunity (PAR-19-334) is a National Institutes of Health (NIH) discretionary grant program designed specifically for small business concerns that have already received SBIR or STTR Phase II or Phase IIB support and are now trying to move that work across the difficult gap between late-stage R and D and real-world commercialization. The central idea is to provide targeted, commercialization-focused technical assistance that is often hard to fund under a typical Phase II or Phase IIB budget, even though it can be critical for getting a product, platform, or technology to market.
This FOA is not meant to restart or broadly expand core laboratory or product-development R and D that belongs in a standard SBIR/STTR research grant. Instead, it is meant to help a company get "commercialization readiness" items done: the specialized planning, documentation, and strategy work that reduces regulatory, business, and execution risk right before commercialization. Examples highlighted in the announcement include preparing documents needed for a Food and Drug Administration (FDA) submission (such as materials that support regulatory interactions), developing and refining an intellectual property strategy (which can involve patent landscaping, freedom-to-operate analysis, and portfolio planning), and planning for a future clinical trial. In other words, the program is aimed at sharpening the commercialization pathway and de-risking next steps so the prior SBIR/STTR-funded technology can move faster toward investors, strategic partners, regulatory milestones, manufacturing readiness, and market entry.
A key boundary in this announcement is that clinical trials are not allowed. Even if the funded project relates to a medical product, diagnostic, therapeutic, or digital health tool, the CRP award under this FOA cannot support the conduct of a clinical trial. What it can support, based on the description, is clinical trial planning and preparatory work as technical assistance, but not enrolling participants or running the trial itself. That distinction matters for applicants because it shapes what activities, timelines, and deliverables can be proposed and budgeted.
From a project management standpoint, NIH makes clear that subcontracting is permissible and, in practice, expected for many of these technical assistance functions. A company might bring in regulatory consultants, IP counsel, reimbursement advisors, quality system specialists, or other expert vendors to complete discrete commercialization-readiness tasks. Even so, the small business applicant must remain in control: the SBC is expected to provide oversight and maintain management of the R and D and overall project execution throughout the award. The program is structured to help a small business accelerate toward commercialization while still ensuring the company, not outside contractors, is driving decisions, integrating the work, and owning the outcomes.
Eligibility is limited to small businesses (the standard SBIR/STTR-eligible small business concerns). Foreign institutions and other non-domestic (non-U.S.) entities are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible. However, the FOA notes that "foreign components" may be allowed as defined under the NIH Grants Policy Statement, meaning certain discrete elements of work could potentially be performed abroad if they meet NIH policy requirements and are appropriately justified, even though the applicant organization itself must be U.S.-based and eligible.
Administratively, this is an NIH grant (Funding Instrument: Grant) under the SBIR mechanism (SB1, R44) and is associated with multiple CFDA program areas spanning health-related research and development (the FOA lists a broad set of CFDA numbers). The opportunity was originally created on August 5, 2019, with an original closing date of July 9, 2020. The listing does not specify an award ceiling or the expected number of awards in the provided source data, so applicants would typically need to consult the full FOA text and any linked NIH Institute or Center guidance to understand budget expectations, durations, review criteria, and institute-specific priorities.
In practical terms, a strong CRP application under this announcement would usually read like a focused commercialization work plan tied directly to a previously funded Phase II or Phase IIB project. It would explain what remains between the current state of the technology and a credible commercialization inflection point, then propose well-scoped technical assistance activities to close those gaps, with clear deliverables (for example, a completed FDA submission package or pre-submission briefing materials, an IP strategy and prioritized patent filing plan, a detailed clinical trial protocol and operational plan without actually conducting the trial, or other similar commercialization-enabling outputs). The overall purpose is to push mature SBIR/STTR-funded innovations out of the lab stage and toward market readiness by paying for the specialized work that makes commercialization feasible and investable, while staying within NIH rules and explicitly excluding clinical trial execution.Apply for PAR 19 334
- The National Institutes of Health in the education, environment, food and nutrition, health sector is offering a public funding opportunity titled "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113, 93.121, 93.172, 93.173, 93.233, 93.242, 93.273, 93.286, 93.350, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.859, 93.866, 93.867.
- This funding opportunity was created on 2019-08-05.
- Applicants must submit their applications by 2020-07-09. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NIH SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (PAR-19-334)
What is the SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance opportunity (PAR-19-334)?
This is an NIH discretionary grant opportunity designed to provide commercialization-focused technical assistance to small business concerns that have already received SBIR or STTR Phase II or Phase IIB support. The goal is to help companies move past the late-stage R&D phase and address the real-world tasks that often block or delay commercialization.
What problem is this funding meant to solve?
It targets the common gap between having a mature SBIR/STTR-funded technology and being truly ready for commercialization. Many of the highest-impact steps needed right before market entry (regulatory documentation, IP strategy, clinical trial planning, and similar items) can be difficult to fund under a typical Phase II/Phase IIB research budget, even though they are critical for de-risking the path to market.
Who is eligible to apply?
Eligibility is limited to SBIR/STTR-eligible small business concerns that have already received SBIR or STTR Phase II or Phase IIB support and are seeking to advance that previously funded work toward commercialization readiness.
Are foreign organizations eligible to apply?
No. Foreign institutions and other non-domestic (non-U.S.) entities are not eligible to apply. Non-domestic components of U.S. organizations are also not eligible.
Are any foreign activities allowed under this FOA?
The FOA notes that "foreign components" may be allowed as defined under the NIH Grants Policy Statement. That means certain discrete elements of work might be performed abroad if they meet NIH policy requirements and are properly justified, even though the applicant organization itself must be a U.S.-based eligible small business.
Is this funding intended to support new core R&D or expand laboratory development?
No. The FOA explicitly distinguishes this program from standard SBIR/STTR research awards. It is not meant to restart or broadly expand core laboratory or product-development R&D that belongs in a typical Phase II or Phase IIB project. It is meant to fund targeted commercialization-readiness activities.
What types of activities does the CRP technical assistance funding support?
It supports specialized planning, documentation, and strategy work that reduces regulatory, business, and execution risk right before commercialization. Examples described include preparing documents needed for an FDA submission (including materials supporting regulatory interactions), developing and refining an intellectual property strategy (such as patent landscaping, freedom-to-operate analysis, and portfolio planning), and planning for a future clinical trial.
Does this FOA allow clinical trials?
No. Clinical trials are not allowed under this FOA. The award cannot support conducting a clinical trial, including enrolling participants or running the trial.
If clinical trials are not allowed, can the project include clinical trial planning?
Yes, based on the description provided. The FOA allows clinical trial planning and preparatory work as commercialization-focused technical assistance, but it does not allow the execution of the clinical trial itself.
What is the intended outcome of a CRP-funded project?
The intended outcome is improved commercialization readiness for a previously SBIR/STTR-funded technology. That typically means completing well-defined, commercialization-enabling outputs that help the company move faster toward regulatory milestones, investors, strategic partners, manufacturing readiness, and market entry.
What are examples of deliverables that would fit this program?
Examples consistent with the FOA description include a completed FDA submission package or pre-submission briefing materials, a documented IP strategy with prioritized next steps for patent filings, and a detailed clinical trial protocol and operational plan (without conducting the trial). More generally, deliverables should be concrete outputs that directly reduce commercialization risk for the prior Phase II/Phase IIB-funded technology.
Can a company use subcontractors or consultants to perform the technical assistance work?
Yes. Subcontracting is permissible and is often expected for specialized commercialization-readiness functions. Companies may bring in outside experts such as regulatory consultants, IP counsel, reimbursement advisors, or quality system specialists to complete discrete tasks.
If subcontractors are used, who is expected to control and manage the project?
The small business applicant is expected to remain in control. NIH expects the SBC to provide oversight and maintain management of the R&D and overall project execution, even when specialized tasks are performed by vendors or subcontractors.
What funding instrument and mechanism are associated with this opportunity?
The listing identifies it as an NIH grant (Funding Instrument: Grant) under the SBIR mechanism, specifically SB1 (R44).
Is the opportunity tied to specific NIH program areas?
It is associated with multiple CFDA program areas spanning health-related research and development. The FOA lists a broad set of CFDA numbers rather than a single narrow program area.
When was this opportunity created and when did it close?
The opportunity was originally created on August 5, 2019, and the original closing date listed is July 9, 2020.
Does the provided listing specify the maximum award amount or the expected number of awards?
No. The provided source data does not specify an award ceiling or the expected number of awards. Applicants would typically need to consult the full FOA text and any linked NIH Institute or Center guidance for budget expectations, duration, review criteria, and institute-specific priorities.
How should a strong application be positioned based on this description?
A strong application would usually read like a focused commercialization work plan that is directly tied to a previously funded Phase II or Phase IIB project. It should clearly describe what remains between the current state of the technology and a credible commercialization inflection point, then propose tightly scoped technical assistance tasks to close those gaps, with clear, measurable deliverables.
What is the key rule applicants need to keep in mind when defining scope?
The key boundary is to keep the scope centered on commercialization readiness technical assistance rather than core R&D expansion, and to avoid proposing any clinical trial conduct. The work should be framed as de-risking and preparing for commercialization, not performing late-stage studies that belong in other funding mechanisms.
Browse more opportunities from the same category: Education, Environment, Food and Nutrition, Health
Next opportunity: Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)
Previous opportunity: Understanding Senescence in Brain Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 19 334
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 19 334) also looked into and applied for these:
| Funding Opportunity |
|---|
| USAID Cambodia Integrated Early Childhood Development Activity Apply for 72044220RFA00001 Funding Number: 72044220RFA00001 Agency: Cambodia USAID-Phnom Penh Category: Education, Environment, Food and Nutrition, Health Funding Amount: $15,000,000 |
| Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) Apply for PAR 20 237 Funding Number: PAR 20 237 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: $500,000 |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed) Apply for PAR 20 128 Funding Number: PAR 20 128 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: Case Dependent |
| Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) Apply for PA 20 252 Funding Number: PA 20 252 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: Case Dependent |
| Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) Apply for PA 20 272 Funding Number: PA 20 272 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: Case Dependent |
| NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) Apply for PA 21 151 Funding Number: PA 21 151 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: Case Dependent |
| Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed) Apply for PAR 21 253 Funding Number: PAR 21 253 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: Case Dependent |
| Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required) Apply for PAR 21 272 Funding Number: PAR 21 272 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: Case Dependent |
| Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) Apply for PAR 21 271 Funding Number: PAR 21 271 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: Case Dependent |
| Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) Apply for PAR 22 078 Funding Number: PAR 22 078 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: Case Dependent |
| Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional) Apply for RFA OD 22 014 Funding Number: RFA OD 22 014 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: Case Dependent |
| Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) Apply for PAR 23 156 Funding Number: PAR 23 156 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: Case Dependent |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) Apply for PAR 23 219 Funding Number: PAR 23 219 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: Case Dependent |
| PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) Apply for PA 23 232 Funding Number: PA 23 232 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: Case Dependent |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) Apply for PAR 23 298 Funding Number: PAR 23 298 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: $500,000 |
| Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) Apply for PAR 24 145 Funding Number: PAR 24 145 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: $125,000 |
| Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) Apply for PAR 24 144 Funding Number: PAR 24 144 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: $100,000 |
| Whole Person Research and Coordination Center (Whole Person RCC) U24 (Clinical Trial Not Allowed) Apply for RFA AT 24 010 Funding Number: RFA AT 24 010 Agency: National Institutes of Health Category: Education, Environment, Food and Nutrition, Health Funding Amount: $1,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 19 334", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.